Global Safety Program Lead - Cell Therapy Oncology & Onco-Hematology

Opportunity:  Global Safety Program Lead - Cell Therapy Oncology & Onco-Hematology

Location: Barcelona, Spain (on-site) 3 days working from the office and 2 days working from home. 

Do you have expertise in, and passion for Patient Safety in Oncology and Onco-Hematology? Would you like to apply your expertise to provide medico-scientific and clinical strategic leadership in a company that follows the science and turns ideas into innovative life changing medicines? Then AstraZeneca might be the one for you! 

AstraZeneca is a global, science-led, patient-focused biopharmaceutical company. Within Global Patient Safety, you will shape the safety strategy of high-impact assets and lead cross-functional teams to optimize benefit–risk and maintain competitive advantage across development and post‑marketing. Working with one of the broadest cell therapy pipelines in the industry offers the possibility to advance the most novel Cell and Gene Therapy (CGT) technologies at all development stages across multiple indications. 

When we put unexpected teams in the same room, we unleash bold thinking with the power to inspire life-changing medicines. In-person working gives us the platform we need to connect, work at pace and challenge perceptions. That’s why we work, on average, a minimum of three days per week from the office. But that doesn’t mean we’re not flexible. We balance the expectation of being in the office while respecting individual flexibility. Join us in our unique and ambitious world. 

As a Global Safety Program Lead - Cell Therapy Oncology & Onco-Hematology, you will report to the Global Safety Head (GSH) of the Cell therapy Patient Safety Unit (CTPSU). You will be a senior leader within the CTPSU and play a key role bringing deep clinical understanding and judgement in benefit risk assessments for AstraZeneca cell therapies in oncology, specifically, but not limited to, the AZD0120 DURGA program in Multiple Myeloma. You will also have a role in shaping the culture of the department and will act as a coach and mentor to more junior Patient Safety staff. You will ensure processes adhere to Good Clinical and Pharmacovigilance Practice and regulatory requirements as well as AZ processes. 

Accountabilities  

In this role, you are accountable to the Global Safety Head, Cell Therapy, for the end‑to‑end safety strategy, delivery, and oversight of AZD0120 Multiple Myeloma program, and potentially other assets, across pre‑clinical, clinical, and post‑marketing. You will: 

• Lead the Safety Strategy & Management Team (SSaMT) and Safety Surveillance Team for assigned asset(s), setting safety goals aligned to therapeutic area and product strategy, and ensuring high‑quality, compliant delivery of safety activities. 

• Own the scientific and clinical safety content for the asset(s), including safety TPP, safety Go/No‑Go criteria, toxicity management guidelines, and safety messaging, integrating inputs from clinical, epidemiology, pre‑clinical, and literature. 

• R